These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 27417323)
1. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine. Rosano GMC; Vitale C; Volterrani M Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323 [TBL] [Abstract][Full Text] [Related]
2. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review. Mody P; Sidhu MS; Brilakis ES; Sacco JD; Banerjee S; Boden WE Cardiol Rev; 2016; 24(4):177-89. PubMed ID: 26274534 [TBL] [Abstract][Full Text] [Related]
3. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report. Yuriivna Osovska N; Vitaliivna Kuzminova N Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133 [TBL] [Abstract][Full Text] [Related]
4. Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease. Cacciapuoti F Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):98-102. PubMed ID: 26944071 [TBL] [Abstract][Full Text] [Related]
5. Ranolazine: A Contemporary Review. Rayner-Hartley E; Sedlak T J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079 [No Abstract] [Full Text] [Related]
6. New Anti-Anginal Drugs: Ranolazine. Cavallino C; Facchini M; Veia A; Bacchni S; Rosso R; Rognoni A; Rametta F; Lupi A; Bongo AS Cardiovasc Hematol Agents Med Chem; 2015; 13(1):14-20. PubMed ID: 25544118 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Angina: Where Are We? Balla C; Pavasini R; Ferrari R Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661 [TBL] [Abstract][Full Text] [Related]
8. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial. Sendón JL; Lee S; Cheng ML; Ben-Yehuda O; Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417 [TBL] [Abstract][Full Text] [Related]
9. Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. Secco GG; Parisi R; Mirabella F; Rognoni A; Lupi A; De Luca G; Marino PN; Fattori R; Cremonesi A; Castriota F Cardiovasc Hematol Agents Med Chem; 2015; 13(1):21-4. PubMed ID: 25544117 [TBL] [Abstract][Full Text] [Related]
10. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes. Manolis A; Kallistratos M; Poulimenos L; Thomopoulos C Am J Med Sci; 2024 Mar; 367(3):155-159. PubMed ID: 38072070 [TBL] [Abstract][Full Text] [Related]
11. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina]. Kanorskii SG; Smolenskaya NV Ter Arkh; 2016; 88(12):33-40. PubMed ID: 28139557 [TBL] [Abstract][Full Text] [Related]
12. Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis. Belsey J; Savelieva I; Mugelli A; Camm AJ Eur J Prev Cardiol; 2015 Jul; 22(7):837-48. PubMed ID: 24776376 [TBL] [Abstract][Full Text] [Related]
13. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence. Ambrosio G; Tamargo J; Grant PJ Diab Vasc Dis Res; 2016 Mar; 13(2):98-112. PubMed ID: 26873904 [TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions. Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510 [TBL] [Abstract][Full Text] [Related]
15. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334 [TBL] [Abstract][Full Text] [Related]
16. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
17. Ranolazine: effects on ischemic heart. Rognoni A; Barbieri L; Cavallino C; Bacchini S; Veia A; Degiovanni A; Rametta F; Nardi F; Lazzero M; Lupi A; Bongo AS Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):197-203. PubMed ID: 23961914 [TBL] [Abstract][Full Text] [Related]
18. Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR). Alexopoulos D; Kochiadakis G; Afthonidis D; Barbetseas J; Kelembekoglou P; Limberi S; Spanos A; Triantafyllidis G Int J Cardiol; 2016 Feb; 205():111-116. PubMed ID: 26730841 [TBL] [Abstract][Full Text] [Related]
19. Stable angina pectoris: the medical management of symptomatic myocardial ischemia. Parker JD; Parker JO Can J Cardiol; 2012; 28(2 Suppl):S70-80. PubMed ID: 22424287 [TBL] [Abstract][Full Text] [Related]
20. Ranolazine: Drug overview and possible role in primary microvascular angina management. Cattaneo M; Porretta AP; Gallino A Int J Cardiol; 2015 Feb; 181():376-81. PubMed ID: 25555283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]